Researcher profile · from public sources
Wei Kang
Targets
- YAP 6
- TP53 3
- METTL3 2
- AMPK 1
- BRAF 1
- CTNNB1 1
- EGFR 1
- ERK 1
- FGFR 1
- GPX4 1
- IGF1R 1
- JNK 1
- KRAS 1
- MAPK 1
- mTOR 1
- STAT3 1
- STK11 1
Filled chips are declared by the researcher; the others come from publications (number of works).
Now
Trials, publications and grants since Nov 2024.
Publication
Publication
Mutant KRAS-m6A Epitranscriptome Axis Promotes Colorectal Cancer and is a Therapeutic Target.
Publication
Publication
CCL5 and GLUT1 define leader cells in collective invasion of colorectal cancer.
Publication
Publication
Trends in MASLD-related cirrhosis and liver cancer across diverse populations, 2010-2023.
Publication
Publication
Publication
Targeting of the m6A eraser ALKBH5 suppresses stemness and chemoresistance of colorectal cancer.
Publication
Publication
Publication
Affiliations
Co-authors
Who links you
Enter another researcher's profile link or ID to see who has published with both of you.
You have published with Jun Yu directly.
- Chi Chun Wong5 works together here · 1 with Jun Yu
Sources: OpenAlex · Updated 4 Nov 2025This is not meCorrect somethingObject to this profile
Is this you? Request a correction or removal: support@frontlightresearch.com